Overall survival using Kaplan-Meier analysis revealed a trend (p = 0.14), with 40% of the mice injected with G-CSF + ISO PBHCs remaining alive by day 100 and exhibiting minimal signs of GvHD, compared to only 10% survival in the G-CSF alone group (Fig. 4B). Here, CSF3 is linked to graft versus host disease.